Imagion Biosystems Limited
OTC: IBXXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Robert Romeo Proulx
- Employees
- 11
- Headquarters
- San Diego, United States
- IPO year
- 2020
- Market cap
- $6.6M
- Website
- https://imagionbiosystems.com
Loading IBXXF…
Loading profile data…Frequently asked questions about IBXXF
What does Imagion Biosystems Limited (IBXXF) do?
Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions. Its operational scope encompasses nan...
Where does IBXXF trade?
Imagion Biosystems Limited (IBXXF) trades on the Other OTC.
What sector is IBXXF in?
Imagion Biosystems Limited (IBXXF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Imagion Biosystems Limited?
Robert Romeo Proulx is the chief executive officer of Imagion Biosystems Limited (IBXXF).
Where is Imagion Biosystems Limited headquartered?
Imagion Biosystems Limited is headquartered in United States.
Does IBXXF pay a dividend?
Imagion Biosystems Limited (IBXXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IBXXF go public?
Imagion Biosystems Limited (IBXXF) completed its initial public offering in 2020.